MiR-429, as other members of miR-200 family, act as a tumor suppressor roles during bladder cancer progression by reducing ZEB1, ZEB2 and restoring E-cadherin which results in downregulation of β-catenin and therefore inhibits cell migratory and invasive ability (Figure 7). Here, CDH1 is linked to urinary bladder cancer.